FAG
NEO icon

Fortitude Advisory Group’s NeoGenomics NEO Stock Holding History

Fortitude Advisory Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-205
Closed -$2K – 887
2022
Q1 		$2K Hold
205
– – ﹤0.01% 1355
2021
Q4 		$7K Buy
+205
New +$8.03K ﹤0.01% 1131

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fortitude Advisory Group's NEO Position: Q2 2022 in Review

Fortitude Advisory Group sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 205 shares — an estimated $2K sold.

Fortitude Advisory Group first reported a position in NEO in Q4 2021 and held it in 2 quarters. The position peaked at $7K in Q4 2021. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Fortitude Advisory Group reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 205 NeoGenomics shares in Q2 2022, an estimated $2K.
  • Fortitude Advisory Group first reported a position in NeoGenomics in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's NeoGenomics position peaked at $7K in Q4 2021.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.